Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-11 8:39 pm Purchase | 2025-06-09 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 2,779,385 37.900% | 1,417,209 (+104.04%) | Filing History |
| 2025-05-15 9:13 pm Purchase | 2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA | John D. Halpern | 398,122 9.600% | 55,683 (+16.26%) | Filing History |
| 2025-05-15 4:42 pm Purchase | 2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA | Konar Shameek | 229,020 5.500% | 229,020 (New Position) | Filing History |
| 2025-05-14 8:39 pm Purchase | 2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA | IAF, LLC | 217,028 5.200% | 38,414 (+21.51%) | Filing History |
| 2025-05-14 2:14 pm Purchase | 2025-03-31 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 414,102 9.900% | 71,656 (+20.92%) | Filing History |
| 2025-04-04 10:55 am Purchase | 2025-04-02 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 1,362,176 32.800% | 252,697 (+22.78%) | Filing History |
| 2025-03-05 5:55 pm Purchase | 2024-10-29 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 1,109,479 32.380% | 1,028,644 (+1272.52%) | Filing History |
| 2025-02-14 9:30 pm Purchase | 2024-12-31 | 13G | Eterna Therapeutics Inc. ERNA | Nicholas Jason Singer | 171,000 4.920% | 130,968 (+327.16%) | Filing History |
| 2025-02-14 8:36 pm Purchase | 2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA | John D. Halpern | 342,439 9.990% | 342,439 (New Position) | Filing History |
| 2025-02-12 5:54 pm Purchase | 2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA | IAF, LLC | 178,614 5.220% | 140,150 (+364.36%) | Filing History |
| 2025-01-28 5:31 pm Purchase | 2024-10-29 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 342,446 9.990% | 272,214 (+387.59%) | Filing History |
| 2024-01-31 07:05 am Purchase | 2023-12-31 | 13G | Eterna Therapeutics Inc. ERNA | John D. Halpern | 36,726 9.990% | 6,574 (+21.80%) | Filing History |
| 2024-01-19 10:31 am Purchase | 2023-12-31 | 13G | Eterna Therapeutics Inc. ERNA | Nicholas Jason Singer | 40,032 9.990% | 2,871 (+7.73%) | Filing History |
| 2023-12-22 12:05 pm Unchanged | 2023-12-14 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 80,835 19.990% | 0 (Unchanged) | Filing History |
| 2023-12-20 3:24 pm Purchase | 2023-12-14 | 13G | Eterna Therapeutics Inc. ERNA | IAF, LLC | 38,464 9.990% | 38,464 (New Position) | Filing History |
| 2023-09-08 06:07 am Unchanged | 2023-07-06 | 13G | Eterna Therapeutics Inc. ERNA | Nicholas Jason Singer | 37,161 9.900% | 0 (Unchanged) | Filing History |
| 2023-09-07 5:26 pm Purchase | 2023-07-13 | 13D | Eterna Therapeutics Inc. ERNA | Charles Cherington | 80,835 19.990% | 43,000 (+113.65%) | Filing History |
| 2023-08-28 4:57 pm Purchase | 2023-04-03 | 13G | Eterna Therapeutics Inc. ERNA | Purchase Capital LLC | 18,695 5.000% | 18,695 (New Position) | Filing History |
| 2023-07-26 5:05 pm Purchase | 2023-04-03 | 13D | Eterna Therapeutics Inc. ERNA | Nicholas Jason Singer | 37,161 9.990% | 37,161 (New Position) | Filing History |
| 2023-07-20 7:52 pm Purchase | 2023-07-14 | 13G | Eterna Therapeutics Inc. ERNA | Freebird Partners LP | 70,232 19.990% | 23,732 (+51.04%) | Filing History |